WTAP-Mediated N6-Methyladenosine Modification Promotes Gastric Cancer Progression by Regulating MAP2K6 Expression

Overview

Journal J Cancer

Specialty Oncology

Date 2025 Feb 24

PMID 39991580

Authors

Shuangshuang Han

Haibin Jiang

Jia Wang

Chao Li

Ting Liu

Mingda Xuan

Bo Tian

Yi Si

Hongyan Zhao

Yunxia Zhao

Zhenlong Zhu

Weifang Yu

Lihong Wang

Affiliations

Soon will be listed here.

Abstract

Wilms tumor 1 associated protein (WTAP) is a key RNA N6-methyladenosine (mA) methylase, which is involved in gastric cancer (GC) development, but its pathogenic mechanism is not clear. This study aims to thoroughly explore the underlying molecular mechanism of WTAP-mediated mA modification in GC pathogenesis. qRT-PCR and immunohistochemistry showed that significantly elevated WTAP expression in GC tissues and is related to advanced age, poorly differentiation, lymph node metastasis and high TNM stage. Overexpression and knockdown of WTAP could promote or inhibit the proliferation, migration and invasion of GC cells , furthermore, suppression of WTAP expression impeded the growth of xenograft tumors Utilizing RNA sequencing, methylated RNA immunoprecipitation (MeRIP) sequencing and bioinformatics analysis, we identified MAP2K6 as direct downstream target of WTAP with mA modification in GC. The interaction between WTAP and MAP2K6 was confirmed by MeRIP-qPCR, luciferase reporter assay, Co-IF and bioinformatics prediction. Immunofluorescence and rescue studies were performed to verify WTAP-mediated mA modification promotes the proliferation, migration, and invasion of GC cells by positively regulating the target gene MAP2K6. This underscores the potential therapeutic significance of targeting the WTAP-MAP2K6 axis in combating GC occurrence and progression.

References

Kuai Y, Gong X, Ding L, Li F, Lei L, Gong Y . Wilms' tumor 1-associating protein plays an aggressive role in diffuse large B-cell lymphoma and forms a complex with BCL6 via Hsp90. Cell Commun Signal. 2018; 16(1):50. PMC: 6108153. DOI: 10.1186/s12964-018-0258-6. View

Heilskov Rasmussen M, Lyskjaer I, Jersie-Christensen R, Tarpgaard L, Primdal-Bengtson B, Nielsen M . miR-625-3p regulates oxaliplatin resistance by targeting MAP2K6-p38 signalling in human colorectal adenocarcinoma cells. Nat Commun. 2016; 7:12436. PMC: 4990699. DOI: 10.1038/ncomms12436. View

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

Ping X, Sun B, Wang L, Xiao W, Yang X, Wang W . Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase. Cell Res. 2014; 24(2):177-89. PMC: 3915904. DOI: 10.1038/cr.2014.3. View

Arnold M, Karim-Kos H, Coebergh J, Byrnes G, Antilla A, Ferlay J . Recent trends in incidence of five common cancers in 26 European countries since 1988: Analysis of the European Cancer Observatory. Eur J Cancer. 2013; 51(9):1164-87. DOI: 10.1016/j.ejca.2013.09.002. View

Yu J, She Y, Yang L, Zhuang M, Han P, Liu J . The m A Readers YTHDF1 and YTHDF2 Synergistically Control Cerebellar Parallel Fiber Growth by Regulating Local Translation of the Key Wnt5a Signaling Components in Axons. Adv Sci (Weinh). 2021; 8(22):e2101329. PMC: 8596126. DOI: 10.1002/advs.202101329. View

Dominissini D, Moshitch-Moshkovitz S, Schwartz S, Salmon-Divon M, Ungar L, Osenberg S . Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq. Nature. 2012; 485(7397):201-6. DOI: 10.1038/nature11112. View

Little N, Hastie N, Davies R . Identification of WTAP, a novel Wilms' tumour 1-associating protein. Hum Mol Genet. 2000; 9(15):2231-9. DOI: 10.1093/oxfordjournals.hmg.a018914. View

Tang J, Wang F, Cheng G, Si S, Sun X, Han J . Wilms' tumor 1-associating protein promotes renal cell carcinoma proliferation by regulating CDK2 mRNA stability. J Exp Clin Cancer Res. 2018; 37(1):40. PMC: 5827993. DOI: 10.1186/s13046-018-0706-6. View

10.

Zheng R, Zhang S, Zeng H, Wang S, Sun K, Chen R . Cancer incidence and mortality in China, 2016. J Natl Cancer Cent. 2024; 2(1):1-9. PMC: 11256658. DOI: 10.1016/j.jncc.2022.02.002. View

11.

Liu X, Liu L, Dong Z, Li J, Yu Y, Chen X . Expression patterns and prognostic value of mA-related genes in colorectal cancer. Am J Transl Res. 2019; 11(7):3972-3991. PMC: 6684930. View

12.

Li Z, Fu J, Li N, Shen L . Quantitative proteome analysis identifies MAP2K6 as potential regulator of LIFR-induced radioresistance in nasopharyngeal carcinoma cells. Biochem Biophys Res Commun. 2018; 505(1):274-281. DOI: 10.1016/j.bbrc.2018.09.020. View

13.

Smyth E, Verheij M, Allum W, Cunningham D, Cervantes A, Arnold D . Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016; 27(suppl 5):v38-v49. DOI: 10.1093/annonc/mdw350. View

14.

Matsumoto T, Kinoshita T, Matsuzaka H, Nakai R, Kirii Y, Yokota K . Crystal structure of non-phosphorylated MAP2K6 in a putative auto-inhibition state. J Biochem. 2012; 151(5):541-9. DOI: 10.1093/jb/mvs023. View

15.

Li B, Liang Z, Seery S, Liu Q, You L, Zhang T . WT1 associated protein promotes metastasis and chemo-resistance to gemcitabine by stabilizing Fak mRNA in pancreatic cancer. Cancer Lett. 2019; 451:48-57. DOI: 10.1016/j.canlet.2019.02.043. View

16.

Zhao H, Xu Y, Xie Y, Zhang L, Gao M, Li S . m6A Regulators Is Differently Expressed and Correlated With Immune Response of Esophageal Cancer. Front Cell Dev Biol. 2021; 9:650023. PMC: 7970005. DOI: 10.3389/fcell.2021.650023. View

17.

Yang Y, Hsu P, Chen Y, Yang Y . Dynamic transcriptomic mA decoration: writers, erasers, readers and functions in RNA metabolism. Cell Res. 2018; 28(6):616-624. PMC: 5993786. DOI: 10.1038/s41422-018-0040-8. View

18.

Weng L, Qiu K, Gao W, Shi C, Shu F . LncRNA PCGEM1 accelerates non-small cell lung cancer progression via sponging miR-433-3p to upregulate WTAP. BMC Pulm Med. 2020; 20(1):213. PMC: 7425603. DOI: 10.1186/s12890-020-01240-5. View

19.

Wu G, Xia J, Yang Z, Chen Y, Jiang W, Yin T . CircASPH promotes KGN cells proliferation through miR-375/MAP2K6 axis in Polycystic Ovary Syndrome. J Cell Mol Med. 2020; 26(6):1817-1825. PMC: 8918404. DOI: 10.1111/jcmm.16231. View

20.

Lin S, Liu K, Zhang Y, Jiang M, Lu R, Folts C . Pharmacological targeting of p38 MAP-Kinase 6 (MAP2K6) inhibits the growth of esophageal adenocarcinoma. Cell Signal. 2018; 51:222-232. DOI: 10.1016/j.cellsig.2018.08.008. View